SAM-e
SAMe (S-Adenosyl-L-Methionine) is a methyl donor cofactor present in every cell, derived from methionine. It is the body's primary methylation agent, donating methyl groups for DNA methylation, neurotransmitter synthesis, phospholipid metabolism, and many other reactions. Unlike most supplements, SAMe is FDA-approved as a prescription drug in many EU countries (for depression and osteoarthritis) but sold as a dietary supplement in the US.
Morning preferred (mild stimulant).
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
SAMe is the universal methyl donor in the cell:
SAMe donates methyl groups to DNA, proteins, phospholipids, neurotransmitters, and many small molecules. Converts to SAH (S-adenosylhomocysteine), then back to homocysteine and methionine via methylation cycle.
Required for synthesis of catecholamines (dopamine, norepinephrine) and serotonin precursor reactions.
Supports neuronal membrane phospholipid synthesis (phosphatidylcholine via methylation of phosphatidylethanolamine).
Stimulates proteoglycan synthesis in chondrocytes - basis of osteoarthritis indication.
Methionine cycle intersects with cysteine and glutathione synthesis - supports hepatic detoxification.
SAMe is unstable and rapidly degraded by stomach acid. Enteric coating or butanedisulfonate stabilization is essential for absorption.
Days 1-14: faster onset than SSRIs.
Weeks 2-4: peak antidepressant effect.
Long-term: sustained effect.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
S-adenosylmethionine supplies methyl groups to many acceptors, including lipids, proteins, RNA, DNA, and a wide range of small molecules.
S-adenosylmethionine supplies methyl groups to many acceptors, including lipids, proteins, RNA, DNA, and a wide range of small molecules.
S-adenosylmethionine tRNA modification: unexpected/unsuspected implications of former/new players.
Evidence scope. Biochemistry review; supports methyl-donor function, not oral dose, efficacy, or timing.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 200-400mg via Oral enteric-coated tablet, 1-3x daily. No checked live PubMed abstract supported this complete molecule/formulation/route/dose/frequency combination.
Primary safety claim: Mild stimulation / anxiety (early dosing). No checked live abstract directly established this as the primary concern for the card's exact formulation and regimen.
Plasma
Enteric-coated
Hours plasma; cumulative neurotransmitter and joint effects over weeks
Oral very poor without enteric coating; enteric-coated ~5-10%
Daily dosing for sustained effects
Hepatic methylation cycle
Storage. Tablet. Cool dry location. Light-sensitive.
Pharmaceutical drug in EU (depression, osteoarthritis, cholestasis). Dietary supplement in US (DSHEA).
Put it to work
Open SAMe straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open SAMe in the app →Go deeper
The complete SAMe walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.